Key result
COVID-19-associated Takotsubo syndrome shows ~80% complete recovery despite frequent inotropic or ventilatory support.
Why the study?
Takotsubo syndrome during the COVID-19 pandemic occurs both as a direct complication of infection and secondary to quarantine stress, but confirming the diagnosis is challenging due to limited coronary angiography and unreliable natriuretic peptide levels, with conflicting results reported regarding quarantine-induced incidence.
This review highlights that Takotsubo syndrome occurs in 2%-4% of COVID-19 patients with a high rate of complete recovery (80%), and proposes a diagnostic algorithm utilizing handheld echocardiography and selective coronary CT or angiography to minimize infectious exposure.
Answers are grounded in this paper and cite their sources.
May inform acute COVID-19 evaluation; leaves open prospective validation of diagnostic algorithms.
The current coronavirus disease 2019 (COVID-19) presents an ongoing medical challenge, as it involves multiple organs, including the cardiovascular system. Takotsubo syndrome (TTS) has been described in the context of COVID-19 in 2 different scenarios: as a direct complication of the infection, and as an indirect outcome secondary to the psychological burden of quarantine and social isolation (ie, stress-induced cardiomyopathy). Confirming the diagnosis of TTS in COVID-19 may be challenging due to the limited use of coronary angiography consistent with the recommended guidelines aimed at minimizing contact with infected individuals. The use of natriuretic peptide as a diagnostic and prognostic marker in this context may not be reliable as this peptide is already elevated in severe cases of COVID-19 regardless of TTS diagnosis. A relatively high incidence of complications has been reported in these cases, probably related to the severity of the underlying infectious disease. Although quarantine-induced stress cardiomyopathy is an unsurprising outcome of the powerful stress resulting from the current pandemic, conflicting results have been reported, and further studies are encouraged to determine the true incidence.
No takes yet. Share an insight, caveat, or question.
Moady et al. (2021) conducted a review in Takotsubo syndrome (TTS) during the COVID-19 pandemic (n=30). SARS-CoV-2 infection and COVID-19 pandemic-related stress was evaluated on Complete recovery from COVID-19-associated Takotsubo syndrome. Takotsubo syndrome complicates an estimated 2%-4% of SARS-CoV-2 infections, with 80% of the 30 reviewed cases achieving complete recovery despite 60% requiring inotropic or ventilatory support.
Synapse has enriched 10 related papers. Consider them for comparative context: